Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anshen Buxin Liuwei Pill for cardiac neurosis
ChiCTR2100044412Phase 4Recruiting
- Sponsor
- Fuwai Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Anshen Buxin Liuwei Pill in functional cardiac symptoms (2 arms), sponsored by Fuwai Hospital. Primary endpoint: Proportion of patients with improvement in Mongolian medicine Heyisheng-type palpitation symptoms at week 8. Started Apr 2021; status: recruiting.
02
Drugs
Anshen Buxin Liuwei Pill
03
Conditions
functional cardiac symptoms
Beyond the preview
Go deeper on ChiCTR2100044412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044412.